ZincL-carnosine suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 murine macrophages cell line via activation of Nrf2/HO-1 signaling pathway
- 11 July 2017
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 39 (5) , 259-267
Abstract
Context: Zinc L-carnosine (ZnC) is a chelate of Zn and L-carnosine and is used clinically in the treatment of peptic ulcer. Objective: In this study, we aim to investigate the involvement of heme oxygenase-1 (HO-1) in the anti-inflammatory effects of ZnC in lipopolysaccharide (LPS)-induced RAW 264.7 murine macrophages. Materials and methods: We used immunoblotting analysis to evaluate the involvement of HO-1 in the anti-inflammatory effects of ZnC and the signaling pathway involved was measured using Dual luciferase reporter assay. Results: Results from immunoblotting analysis demonstrated that pretreatment of cells with ZnC enhanced the expression of HO-1 in RAW 264.7 cells. Pretreatment of cells with HO-1 inhibitor (tin protoporphyrin IX dichloride) significantly attenuated the inhibitory effects of ZnC on nitric oxide (NO) production, inducible nitric oxide synthase (iNOS) expression and NF-κB activation in LPS-induced RAW 264.7 cells, suggesting that HO-1 play an important role in the suppression of inflammatory responses induced by ZnC. Furthermore, results from co-immunoprecipitation of Nrf2 and Keap1 and dual luciferase reporter assay showed that pretreatment of ZnC was able to activate the Nrf2 signaling pathway. Treatment of cells with p38 inhibitor (SB203580), c-Jun N-terminal kinase inhibitor (SP600125), and MEK 1/2 inhibitor (U0126) did not significantly suppress the induction of HO-1 by ZnC. Moreover, our present findings suggest that the effects of ZnC on NO production, HO-1 expression, and Nrf2 activation were attributed to its Zn subcomponent, but not l-carnosine. Conclusion: Pretreatment with ZnC was able to activate Nrf2/HO-1 signaling pathway, thus suppressing the expression of inflammatory mediators, such as NO and iNOS in LPS-induced RAW 264.7 cells.Keywords
Funding Information
- Ministry of Higher Education, Malaysia (FRGS/1/, /SKK03/UKM/03/1)
- Universiti Kebangsaan Malaysia (DIP-, –024)
This publication has 37 references indexed in Scilit:
- Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammationTranslational Research, 2016
- Zinc deficiency or excess within the physiological range increases genome instability and cytotoxicity, respectively, in human oral keratinocyte cellsGenes & Nutrition, 2011
- The effect of zinc sulphate and zinc carnosine on genome stability and cytotoxicity in the WIL2-NS human lymphoblastoid cell lineMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2011
- Sterile inflammation: sensing and reacting to damageNature Reviews Immunology, 2010
- Mechanisms of Cell Protection by Heme Oxygenase-1Annual Review of Pharmacology and Toxicology, 2010
- Role of nitric oxide in inflammatory diseasesInflammopharmacology, 2007
- iNOS-mediated nitric oxide production and its regulationLife Sciences, 2004
- Anti-Inflammatory Actions of the Heme Oxygenase-1 PathwayCurrent Pharmaceutical Design, 2003
- Reduced stress defense in heme oxygenase 1-deficient cellsProceedings of the National Academy of Sciences, 1997
- Heme oxygenase: A novel target for the modulation of inflammatory responseNature Medicine, 1996